Does CACTINOMYCIN Cause Product use in unapproved indication? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Product use in unapproved indication have been filed in association with CACTINOMYCIN. This represents 37.5% of all adverse event reports for CACTINOMYCIN.
6
Reports of Product use in unapproved indication with CACTINOMYCIN
37.5%
of all CACTINOMYCIN reports
1
Deaths
1
Hospitalizations
How Dangerous Is Product use in unapproved indication From CACTINOMYCIN?
Of the 6 reports, 1 (16.7%) resulted in death, 1 (16.7%) required hospitalization, and 1 (16.7%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CACTINOMYCIN. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does CACTINOMYCIN Cause?
Acute myeloid leukaemia (6)
Anaemia (5)
Hepatosplenomegaly (5)
Hyperleukocytosis (5)
Thrombocytopenia (5)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)